Nu Skin Enterprises Inc (NUS)

Cash ratio

Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019
Cash and cash equivalents US$ in thousands 256,057 264,725 339,593 402,683 335,630
Short-term investments US$ in thousands 11,759 13,784 15,221 21,216 8,413
Total current liabilities US$ in thousands 328,871 359,243 529,694 542,856 356,760
Cash ratio 0.81 0.78 0.67 0.78 0.96

December 31, 2023 calculation

Cash ratio = (Cash and cash equivalents + Short-term investments) ÷ Total current liabilities
= ($256,057K + $11,759K) ÷ $328,871K
= 0.81

The cash ratio of Nu Skin Enterprises, Inc. has shown some fluctuation over the past five years, ranging from 0.82 to 1.16. The cash ratio measures the company's ability to cover its short-term liabilities with its cash and cash equivalents.

In 2023, the cash ratio stands at 1.06, indicating that the company has $1.06 in cash and cash equivalents for every $1 of its current liabilities. This suggests that Nu Skin Enterprises, Inc. has a relatively strong liquidity position in 2023.

Comparing this to previous years, we can see that the company's liquidity position has improved compared to 2021 when the cash ratio was 0.82. However, it is slightly lower than the 2019 ratio of 1.16.

Overall, the upward trend in the cash ratio from 2021 to 2023 indicates that Nu Skin Enterprises, Inc. has been increasing its ability to cover its short-term obligations with its available cash and cash equivalents. This suggests an improving liquidity position for the company.


Peer comparison

Dec 31, 2023

Company name
Symbol
Cash ratio
Nu Skin Enterprises Inc
NUS
0.81
Cardinal Health Inc
CAH
0.15
Cencora Inc.
COR
0.05
McKesson Corporation
MCK
0.09